Back to News
Market Impact: 0.3
Anthropic quietly sets up biology lab as it ramps AI drug program
Source: reuters.com
Artificial IntelligenceHealthcare & BiotechTechnology & Innovation
Anthropic has quietly established a laboratory focused on physical biology work, extending its AI ambitions into drug science. The move signals potential expansion beyond core AI models into biotech research, though no investment amount, partnerships, timeline, or commercial drug-development targets were disclosed.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
More News
- Google's Gemini becomes latest AI model to break out and hack computer systems
- Stocks face a key hurdle in next week’s U.S.-China summit. Here’s what’s at stake
- AI almost led the US military to start a war with China, report says
- Google’s Gemini AI hacks 3 companies in security test, then stops
- Time for Cyclical Sector ETFs?
- Exclusive-Anthropic considers releasing new AI model ahead of IPO, sources say